Pediatrix Medical Group, Inc. - 8-K Filing

Pediatrix appoints David Haddock as Executive Vice President and General Counsel; Mary Ann Moore transitions out of role by October 31, 2026 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure)

SEC EDGAR ·

Tickers: $MD

Read the full article at SEC EDGAR

More Regulatory news